Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 219 of the 222 references it cites were found in a registry or an index.

Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways

Abstract

Colorectal cancer (CRC) is a complex disease characterized by genetic and epigenetic alterations, playing a crucial role in its development and progression. This review aims to provide insights into the emerging landscape of these alterations in CRC pathogenesis to develop effective diagnostic tools and targeted therapies. Genetic alterations in signaling pathways such as Wnt/β-catenin, and PI3K/Akt/mTOR are pivotal in CRC development. Genetic profiling has identified distinct molecular subtypes, enabling personalized treatment strategies. Epigenetic modifications, including DNA methylation and histone modifications, also contribute to CRC pathogenesis by influencing critical cellular processes through gene silencing or activation. Non-coding RNAs have emerged as essential players in epigenetic regulation and CRC progression. Recent research highlights the interplay between genetic and epigenetic alterations in CRC. Genetic mutations can affect epigenetic modifications, leading to dysregulated gene expression and signaling cascades. Conversely, epigenetic changes can modulate genetic expression, amplifying or dampening the effects of genetic alterations. Advancements in understanding pathogenic pathways have potential clinical applications. Identifying genetic and epigenetic markers as diagnostic and prognostic biomarkers promises more accurate risk assessment and early detection. Challenges remain, including validating biomarkers and developing robust therapeutic strategies…

Overview

Integrity signals

Registry

Crossref · 10.1007/s12032-023-02201-8

Cites

219 of 219 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 222 references

Research works printed but not linked: 10

  1. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Gastroenterol Rev/Przegląd Gastroenterologiczny. 2019;14:89–103.
  2. Abbasi, W.; French, C.E.; Rockowitz, S.; Kenna, M.A.; Eliot Shearer, A. Evaluation of copy number variants for genetic hearing loss: a review of current approaches and recent findings. Human Genetics 2022, 1–14.
  3. Mueller D, Győrffy B. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochimica et Biophysica Acta (BBA). 2022;1877:188722.
  4. Ali A, Ahmad E, Verma R, Sahu P, Nimisha; Srivastava, S., Saluja, S.S. Identification of therapeutic targets of gallbladder cancer using multi-omics approach. Brief Funct Genom. 2023;22:109–22.
  5. Dotolo S, Esposito Abate R, Roma C, Guido D, Preziosi A, Tropea B, Palluzzi F, Giacò L, Normanno N. Bioinformatics: from NGS data to biological complexity in variant detection and oncological clinical practice. Biomedicines. 2022. https://doi.org/10.3390/biomedicines10092074. · DOI
  6. Bian J, Dannappel M, Wan C, Firestein R. Transcriptional regulation of Wnt/β-catenin pathway in colorectal cancer. Cells. 2020. https://doi.org/10.3390/cells9092125. · DOI · Paper page
  7. Ortiz-Barahona V, Joshi RS, Esteller M. Use of DNA methylation profiling in translational oncology. Semin Cancer Biol. 2022;83:523–35. https://doi.org/10.1016/j.semcancer.2020.12.011. · DOI
  8. Lizardo DY, Kuang C, Hao S, Yu J, Huang Y, Zhang L. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside. Biochem Biophys Acta. 2020;1874:188447.
  9. Armaghany T, Wilson JD, Chu Q, Mills G. Genetic alterations in colorectal cancer. Gastrointest Cancer Res. 2012;5:19–27.
  10. Testa U, Pelosi E, Castelli G. Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. J Med Sci. 2018;6:31.

Cited by

See all 30

Metadata

Authors
Postwala, H., Shah, Y., Parekh, P. S., & Chorawala, M. R.
Affiliations
Gujarat University (IN)
Corresponding author
Chorawala, Mehul R.
Venue
Medical Oncology
Published
2023-10-19
Volume
40
Issue
11
Pages
334-334
ISSN
  • 1357-0560 (ISSN-L)
  • 1559-131X
OpenAlex
W4387765740
Cited by
26
References
222
Citations by year
2026: 7 · 2025: 12 · 2024: 7
FWCI
1.18
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Medical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
colorectal cancer, genetic alterations, epigenetic modifications, Wnt/β-catenin signaling, PI3K/AKT/mTOR pathway, DNA methylation, histone modifications, non-coding RNA, molecular subtypes, biomarkers, tumor progression, gene silencing, targeted therapy
MeSH terms
Humans, Colorectal Neoplasms, Biomarkers, Gene Expression Regulation, Neoplastic, DNA Methylation, Phosphatidylinositol 3-Kinases, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways. https://app.cochat.ai/papers/10.1007/s12032-023-02201-8
The paper
Postwala, H., Shah, Y., Parekh, P. S., & Chorawala, M. R. (2023). Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways. Medical Oncology. https://doi.org/10.1007/s12032-023-02201-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.